{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:30:37Z","timestamp":1772915437864,"version":"3.50.1"},"reference-count":52,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1160,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropathology Appl Neurobio"],"published-print":{"date-parts":[[1998,11]]},"abstract":"<jats:p>Mitotic index &gt;6, proliferating cell nuclear antigen (PCNA) index &gt;5%, high tumour grade and absence of progesterone receptors (PR) are significant predictors for poor outcome in meningiomas. Since MIB\u20101 (Ki\u201067) is a more specific cell proliferation marker, and overexpression of TGF\u2010alpha is also associated with tumour progression, we compared the prognostic significance of these factors with the other indices. Intracranial meningiomas from 21 men and 36 women (age 54.5\u00b11.7, mean\u00b1sem) were classified as 24 benign, 24 atypical and nine malignant. Twenty\u2010one of the 57 tumours recurred (mean interval to recurrence was 57.3\u00b113.1 months). The mean follow\u2010up period for patients without tumour recurrence was 81.9\u00b18.7 months. MIB\u20101 labelling index (LI) was expressed as percentage of labelled nuclei to total tumour nuclei counted in the most densely labelled areas. Analysis of variance revealed significant differences between tumour grades for MIB\u20101 labelling indices (0.75\u00b10.21 for benign, 3.2\u00b10.57 for atypical, 6.04\u00b11.48 for malignant; <jats:italic>P<\/jats:italic>\u22640.0066), and between malignant and non\u2010malignant meningiomas for TGF\u03b1 staining scores (<jats:italic>P<\/jats:italic>\u22640.029). MIB\u20101 LI also correlated with mitotic and PCNA indices (<jats:italic>P<\/jats:italic>\u22640.0001), but not with age of the patients. Male patients had higher tumour MIB\u20101 LI than females (<jats:italic>P<\/jats:italic>\u22640.0128). Univariate analysis indicated that MIB\u20101 LI&gt;3%, TGF\u03b1 score &gt;4 (scoring scale 0\u20135), mitotic index &gt;6, and negative PR status were significant factors for worse outcome. Higher MIB\u20101 LI, TGF\u03b1 score and mitotic index as continuous variables were also significant negative predictors. With multivariate analysis, both MIB\u20101 LI and TGF\u03b1 score remained significant factors when paired with all other variables: TGF\u03b1 or MIB\u20101 LI, respectively, mitosis, PCNA, tumour grade, PR status, age, sex, postoperative radiation therapy. We conclude that MIB\u20101 LI and TGF\u03b1 score are important independent prognostic indicators for patients with meningiomas.<\/jats:p>","DOI":"10.1046\/j.1365-2990.1998.00150.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T14:50:29Z","timestamp":1047480629000},"page":"441-452","source":"Crossref","is-referenced-by-count":67,"title":["MIB\u20101(Ki\u201067) index and transforming growth factor\u2010alpha (TGF\u03b1) immunoreactivity are significant prognostic predictors for meningiomas"],"prefix":"10.1111","volume":"24","author":[{"family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Efird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hedley\u2010Whyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1983.58.1.0051"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198705000-00003"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.105.4.1549"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198609000-00003"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711680404"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00697392"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1996.84.1.0085"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240320406"},{"key":"e_1_2_6_10_2","first-page":"707","article-title":"Synthesis of messenger RNAs for transforming growth factor \u03b1 and \u03b2 and the epidermal growth factor receptor by human tumors.","volume":"47","author":"Derynck R","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00692849"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00182088"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1991.74.6.0861"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.135.1.107"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199405000-00005"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.86.1.0113"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199708000-00003"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(86)90259-4"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(86)90233-8"},{"key":"e_1_2_6_20_2","first-page":"1471","article-title":"Growth fraction estimation of malignant lymphomas in formalin\u2010fixed paraffin\u2010embedded tissue using anti\u2010PCNA\/cyclin 19A2: correlation with Ki\u201067 labeling.","volume":"138","author":"Kamel OW","year":"1991","journal-title":"Am J Pathol"},{"key":"e_1_2_6_21_2","first-page":"629","article-title":"New Ki\u201067\u2010equivalent murine monoclonal antibodies (MIB 1\u20133) generated against bacterially expressed parts of the Ki\u201067 cDNA containing three 62 base pair repetitive elements encoding for the Ki\u201067 epitope.","volume":"68","author":"Key G","year":"1993","journal-title":"Lab Invest"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/107.3.321"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(96)90107-0"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.5.12.3644"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01054768"},{"key":"e_1_2_6_26_2","first-page":"137","article-title":"Ki\u201067 immunoreactivity in meningiomas \u2013 determination of the proliferative potential of meningiomas using the monoclonal antibody Ki\u201067.","volume":"16","author":"Madsen C","year":"1997","journal-title":"Clin Neuropathol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1992.77.4.0616"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(86)90081-9"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.15.4684"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6320373"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1016\/S0021-9258(17)43959-7","article-title":"Epidermal growth factor\u2010like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells.","volume":"258","author":"Massague J","year":"1983","journal-title":"J Biol Chem"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050458"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1985.62.1.0018"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199404000-00016"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00687579"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199509000-00016"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199512000-00003"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.131.4.1657"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19941215)74:12<3176::AID-CNCR2820741217>3.0.CO;2-N"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19941001)74:7<1921::AID-CNCR2820740716>3.0.CO;2-9"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(90)90081-U"},{"key":"e_1_2_6_42_2","first-page":"1189","article-title":"Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.","volume":"55","author":"Samoto K","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_43_2","first-page":"895","article-title":"Immunocytochemical study of transforming growth factor expresssion in benign and malignant gliomas.","volume":"134","author":"Samuels V","year":"1989","journal-title":"Am J Pathol"},{"key":"e_1_2_6_44_2","first-page":"488","article-title":"Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings.","volume":"177","author":"Sanfilippo JS","year":"1993","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_6_45_2","first-page":"1839","article-title":"Expression of transforming growth factor alpha in human gliomas.","volume":"5","author":"Schlegel U","year":"1990","journal-title":"Oncogene"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2422759"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930101)71:1<199::AID-CNCR2820710131>3.0.CO;2-S"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19881115)62:10<2139::AID-CNCR2820621013>3.0.CO;2-G"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(96)80055-0"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1981.55.6.0929"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.9.5258"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<373::AID-CNCR21>3.0.CO;2-Y"},{"key":"e_1_2_6_53_2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1227\/00006123-198802000-00015","article-title":"Identification of proliferating cells in human gliomas using the monoclonal antibody Ki\u201067.","volume":"22","author":"Zuber P","year":"1988","journal-title":"Neurosurgery"}],"container-title":["Neuropathology and Applied Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2990.1998.00150.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2990.1998.00150.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2990.1998.00150.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2990.1998.00150.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T01:45:20Z","timestamp":1694396720000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2990.1998.00150.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1046\/j.1365-2990.1998.00150.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2990.1998.00150.x","archive":["Portico"],"relation":{},"ISSN":["0305-1846","1365-2990"],"issn-type":[{"value":"0305-1846","type":"print"},{"value":"1365-2990","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}